Skip to main content
. 2020 Dec 2;12(12):e11847. doi: 10.7759/cureus.11847

Table 5. Kappa for patients at or above target dose.

aThe Kappa coefficient for Aripiprazole could not be calculated because no patients fell into the non-adherent definition.

bThe Kappa coefficient for Clozapine could not be calculated because no patients fell into the non-adherent definition.

Drug Kappa (95% CI)
All drugs combined (n=42) 0.14 (-0.24 to 0.52)
Risperidone (n=10) 1.0 (1.0–1.0)
Aripiprazole (n=8) N/Aa
Clozapine (n=6) N/Ab
Quetiapine (n=8) -0.20 (-0.49 to 0.09)
Olanzapine (n=10) -0.11 (-0.26 to 0.04)